April Jorge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Risks for Hydroxychloroquine Retinopathy Described in Detail

Including over 4670 patients, this is "the largest cohort study to date looking specifically at the association of [HCQ] retinopathy with risk factors," one expert said.

United statesBaylor college of medicineChristina wengApril jorgeDivision of rheumatologyNetwork open onAmerican academy of ophthalmologyMassachusetts general hospitalBaylor collegeMedscape medicalKaiser permanente northern californiaMore roomAmerican academyMedscape medical news

SGLT2 Inhibitors Begin to Show Potential in Rheumatology

Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.

United statesUnited kingdomBristol myers squibbMichelle petriApril jorgeChio yokoseBernard cheungJohns hopkinsJohns hopkins universityCrystal associated disease networkEuropean alliance of associationsAmerican society of healthUniversity of marylandHarvard medical schoolResearch hints at goutAmerican college of rheumatology

SGLT2 inhibitors have potential role in reducing cardiac, renal risks in lupus

SGLT2 inhibitors have potential role in reducing cardiac, renal risks in lupus
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesByrob volanskyApril jorgeShenaz baghaMassachusetts general hospital

Best Estimates Made for Hydroxychloroquine Retinopathy Risk

Hydroxychloroquine dosing and retinopathy risk have long been a concern with its use. A new, comprehensive study finds that retinopathy diagnosis with cumulative dosing is actually low.

United statesRonald mellesNilanjana boseApril jorgeMichael marmorRukhsanag mirzaMemorial hermann health systemAmerican academy of dermatologyAmerican college of rheumatologyHarvard medical schoolAmerican academy of ophthalmologyNorthwestern university feinberg school of medicineRheumatologic dermatology societyKaiser permanente northern californiaAmerican collegeAmerican academy

ACR, EULAR Roll Out Updated Antiphospholipid Syndrome Criteria

A joint planning group proposes updates to 16-year-old criteria for classifying antiphospholipid syndrome.

New yorkUnited statesHospital for special surgeryMedha barbhaiyaApril jorgeDoruk erkanEuropean alliance of associationsLorraine university in nancyAmerican college of rheumatologyAmerican collegeEuropean allianceLorraine universitySpecial surgeryWeill cornell medicineWhy these updates areMassachusetts general hospital